Dopamine-modified poly(ε-caprolactone) micelles for pH controlled delivery of bortezomib

Lei Liu,Shuaichao Wang,Peilan Qi,Shiyong Song,Yanwei Yang,Jiahua Shi,Guang Han

DOI: https://doi.org/10.1016/j.ijpharm.2020.119885

IF: 6.51

2020-11-01

International Journal of Pharmaceutics

Abstract:<p>Poly(ethylene glycol)-poly(ε-caprolactone) (PEG-b-PCL) micelles have been widely used as drug delivery vehicles for cancer therapies. Because of the lack of functional groups, the use of PEG-b-PCL in drug delivery system is greatly limited and structural modifications is needed. In this work, chemical modification at the terminus of PEG-b-PCL was performed via the "grafting from" polymerization method. A poly(dopamine methyl acrylamide) segment was introduced containing multiple catechol groups, which could attach bortezomib (BTZ) to the chain of the polymer through the formation of a pH-sensitive borate bond. This method greatly enhanced the loading capacity of BTZ into the micelles. Additionally, the controlled release of BTZ in response to the acidic environment of a tumor was realized. High loading capacity, stimuli-responsiveness, biodegradability, and compatibility were integrated in the PEG-b-PCL-based system. <em>In vitro</em> and <em>in vivo</em> studies demonstrated that superior tumor inhibition without obvious side effects can be achieved by the BTZ-loaded PEG-b-PCL-b-PDMA micelles.</p>

pharmacology & pharmacy